UAE now has its first clinical framework for weight-loss injections, marking a major shift in how obesity treatments are regulated, prescribed, and monitored across the country. The move comes amid surging demand for GLP-1 medications and growing concerns over misuse, safety, and supply.
Key Development
The United Arab Emirates has introduced a structured clinical framework to regulate the use of weight-loss injections, including widely used GLP-1 therapies such as semaglutide and tirzepatide.
The framework is designed to standardise how these treatments are prescribed and managed, ensuring they are used strictly for medical purposes rather than cosmetic demand.
Key components of the framework are expected to include:
- Clear eligibility criteria based on Body Mass Index and health conditions
- Mandatory medical supervision and follow-up
- Standardised dosing and treatment protocols
- Stronger controls on prescription and supply chains
This comes as demand for injections like Ozempic, Wegovy, and Mounjaro has surged across the UAE, driven partly by social media and global trends.
Why It Matters
The introduction of a clinical framework is a critical step in addressing both the opportunities and risks associated with weight-loss injections.
For patients:
- Ensures safe and medically appropriate use
- Reduces risks linked to self-medication or misuse
- Improves long-term health outcomes through structured care
For the healthcare system:
- Prevents shortages of essential medications for diabetes patients
- Standardises treatment across clinics and hospitals
- Enhances oversight of a rapidly growing pharmaceutical segment
For regulators:
- Strengthens control over unlicensed or counterfeit drugs
- Aligns UAE practices with global medical standards
- Supports evidence-based healthcare delivery
Doctors in the UAE have already warned that these injections are not “magic solutions” and should only be used under strict medical guidance.
Bigger Picture
The UAE’s move reflects a broader transformation in obesity treatment, where advanced medications are becoming a central part of healthcare strategies.
Globally and in the UAE:
- GLP-1 injections are among the most effective weight-loss treatments available
- Demand has led to supply shortages and rising costs in some markets
- Regulators are increasing scrutiny to ensure safe usage
At the same time, the UAE is pushing forward with pharmaceutical innovation. In April 2026, the Emirates Drug Establishment approved Foundayo, a daily oral weight-loss pill, offering a needle-free alternative to injections.
This dual approach highlights a key strategy:
- Regulate existing injectable treatments more strictly
- Introduce next-generation therapies to improve accessibility and safety
With obesity affecting a significant portion of the population, tackling the issue is becoming a national healthcare priority.
What Happens Next
The clinical framework is expected to reshape how weight-loss injections are prescribed and accessed across the UAE.
Key developments to watch:
- Wider enforcement of eligibility and prescribing rules
- Increased use of multidisciplinary weight management programmes
- Expansion of alternatives such as oral therapies
- Continued monitoring of supply and demand
Healthcare providers are likely to adopt more structured patient pathways, combining medication with nutrition, exercise, and long-term follow-up.
The UAE’s approach signals a shift from trend-driven use of weight-loss injections to a more controlled, medicalised system focused on safety and sustainability.
FAQs
What is the UAE’s clinical framework for weight-loss injections?
It is a set of guidelines regulating how weight-loss injections are prescribed, monitored, and used safely.
Why was this framework introduced?
To prevent misuse, ensure patient safety, and manage rising demand for these medications.
Who can qualify for weight-loss injections?
Typically, individuals with a BMI of 30 or higher, or 27 with related health conditions.
Are these injections safe?
Yes, when prescribed and monitored by licensed medical professionals.
Are there alternatives to injections?
Yes, the UAE has approved new oral treatments like Foundayo as alternatives.
